Quercetin & Connective Tissue Disorders
Published May 4th, 2026
A Root-Cause Approach to Inflammation, Mast Cells, and Structural Integrity
Dr. Carmen Llavona Hopkinson, PhD, BCDFM · Eirene Integrative Wellness · Healing the Whole You
If you’re living with hypermobile Ehlers-Danlos syndrome (hEDS), POTS, or mast cell activation syndrome (MCAS) — or some combination of all three — you know that conventional medicine often offers more labels than solutions. At Eirene, we go deeper. Quercetin is one of the most clinically compelling plant compounds we use to support the complex, overlapping biology that drives these conditions.
What Is Quercetin?
Quercetin is a polyphenolic flavonoid found abundantly in foods like capers, red onions, apples, and green tea. It has been studied extensively for its antioxidant, anti-inflammatory, and mast cell-stabilizing properties — making it particularly relevant for the connective tissue disorder (CTD) triad of hEDS, POTS, and MCAS.
Unlike single-target pharmaceuticals, quercetin operates through multiple biological pathways simultaneously. This “pleiotropic” quality makes it especially valuable in the kind of complex, multi-system presentations we see in connective tissue clients.
How Quercetin Works: Key Mechanisms
Mast Cell Stabilization: Inhibits histamine release and IgE-mediated degranulation by blocking calcium influx into mast cells.
NF-κB Inhibition: Downregulates nuclear factor kappa-B, reducing pro-inflammatory cytokine production across tissues.
Antioxidant Defense: Scavenges reactive oxygen species and activates Nrf2 — the master regulator of antioxidant gene expression.
Vascular Support: Strengthens capillary integrity, reduces vascular permeability, and modulates autonomic tone relevant to POTS.
Collagen Protection: Inhibits matrix metalloproteinases (MMPs) that degrade extracellular matrix and connective tissue scaffolding.
Gut Barrier Integrity: Upregulates tight junction proteins (occludin, claudin-1), helping to seal a leaky gut often seen in CTD.
Quercetin in the Context of hEDS, POTS & MCAS
These three conditions frequently co-occur — and their shared biology makes quercetin a logical intervention point. Here’s how each condition intersects with quercetin’s mechanisms:
HYPERMOBILE EHLERS-DANLOS SYNDROME (HEDS)
hEDS involves defective collagen synthesis and extracellular matrix dysfunction. Elevated MMPs — enzymes that break down collagen — are frequently observed. Quercetin’s MMP-inhibiting activity, combined with its ability to reduce inflammatory load on already fragile connective tissues, makes it a meaningful adjunct to structural support protocols. Early research also suggests quercetin may influence TGF-β signaling pathways implicated in connective tissue remodeling.
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS)
POTS involves dysregulated autonomic nervous system function, vascular pooling, and often increased vascular permeability. Quercetin has demonstrated vasodilatory effects via nitric oxide pathway modulation, and its ability to reduce mast cell–mediated vascular inflammation may help stabilize symptoms. Some clients with hyperadrenergic POTS also benefit from quercetin’s modest modulatory effects on norepinephrine pathways, though this remains an emerging ...
MAST CELL ACTIVATION SYNDROME (MCAS)
Quercetin is one of the most evidence-backed natural mast cell stabilizers available. It inhibits the release of histamine, tryptase, prostaglandins, and leukotrienes from mast cells — without the side effect burden of pharmaceutical antihistamines. For clients with reactive, multi-system MCAS presentations involving skin, gut, cardiovascular, and neurological symptoms, quercetin is often a foundational piece of the initial protocol.
CLINICAL PEARL
The overlap between MCAS and gut permeability is significant: mast cells concentrated in the intestinal mucosa can drive a cycle of inflammation and barrier breakdown. Quercetin addresses both ends of this loop simultaneously.
The Bioavailability Challenge — and How to Solve It
One of quercetin’s historical limitations as a supplement has been its poor bioavailability in standard aglycone form. Fortunately, several delivery strategies have meaningfully changed this — and selecting the right formulation for each client’s picture is part of how we build effective protocols at Eirene.
Quercetin phytosome: Bound to sunflower lecithin; up to 20× more bioavailable than standard quercetin
Quercetin dihydrate: More soluble than aglycone; widely used in research
Quercetin + bromelain: Bromelain enhances absorption and adds synergistic antiinflammatory action
Isoquercetin / quercetin glycoside: Water-soluble form with superior GI absorption
PRACTITIONER NOTE
Formulation and dosing should always be individualized. The right form for one client’s MCAS-dominant picture may differ significantly from what’s appropriate for someone whose primary driver is vascular instability or oxidative stress. Please work with your Eirene practitioner before starting any quercetin protocol.
EIRENE WELLNESS APOTHECARY
Professional-grade quercetin formulations, curated and dispensed through our Fullscript store.
Quercetin Synergies Worth Knowing
VITAMIN C
Perhaps the most important synergy: vitamin C and quercetin mutually enhance each other’s stability and bioavailability. Vitamin C also regenerates oxidized quercetin back to its active form. For connective tissue clients, this combination additionally supports collagen hydroxylation — a process that is often impaired even when dietary protein is adequate.
LUTEOLIN
Another flavonoid with potent mast cell–stabilizing and neuroinflammatory benefits. The combination of quercetin and luteolin is increasingly used in MCAS protocols, particularly where neurological symptoms and brain fog are prominent.
DIGESTIVE ENZYMES (BROMELAIN / PAPAIN)
Beyond improving quercetin absorption, proteolytic enzymes reduce circulating immune complexes and inflammatory mediators — an important consideration in CTD where chronic low-grade inflammation is a constant background driver.
NAC (N-ACETYLCYSTEINE)
For clients with oxidative stress burden — measurable on an Organic Acids Test (OAT) — combining quercetin with NAC supports glutathione regeneration and addresses mitochondrial dysfunction that often underlies fatigue in EDS and POTS.
What the Research Says
While large-scale randomized controlled trials specific to EDS and MCAS remain limited, the mechanistic literature is robust and the clinical signal in case series and observational work is consistent. Key study findings relevant to our client population include:
A 2016 study published in Molecules confirmed quercetin’s inhibition of IgE-mediated mast cell activation across multiple tissue types. Research in Journal of Allergy and Clinical Immunology has highlighted quercetin’s superiority to cromolyn sodium in inhibiting certain inflammatory mediators. For gut permeability, studies demonstrate upregulation of ZO-1, occludin, and claudin-1 with quercetin supplementation — proteins directly relevant to intestinal barrier function, a significant concern in the CTD population.
A NOTE ON TESTING
Before building a quercetin-based protocol, we often assess baseline inflammatory markers (hsCRP, IL-6), oxidative stress via OAT, and gut permeability markers. This allows us to track whether the intervention is actually moving the needle for you as an individual — not just in a study population.
Who Should Be Thoughtful About Quercetin?
Quercetin is generally well-tolerated at typical supplemental doses. However, there are considerations worth discussing with your practitioner:
At very high doses (greater than 1,000 mg/day), quercetin may interact with certain medications metabolized by CYP3A4 and CYP2C8 enzymes, potentially affecting levels of drugs including some anticoagulants, cyclosporine, and statins. There is also emerging evidence of effects on thyroid peroxidase at very high doses — worth noting for those with Hashimoto’s thyroiditis, a condition with significant overlap in the connective tissue community. Quercetin should also be used thoughtfully in pregnancy.
This is precisely why a personalized, supervised approach — not a self-directed supplement stack — produces better and safer outcomes.
The Bigger Picture: Root-Cause Thinking
Quercetin is not a cure for EDS, POTS, or MCAS. What it represents is a functionally intelligent tool — one that addresses the inflammatory, immune, vascular, and structural dimensions of these conditions simultaneously. Used within a comprehensive protocol that includes dietary optimization, nervous system support, appropriate movement therapy, and hormonal and mitochondrial evaluation, quercetin can be a meaningful piece of the healing puzzle.
At Eirene Integrative Wellness, we approach connective tissue disorders with the respect they deserve: as multi-system, whole-person conditions that require nuanced, individualized care. If you’ve been told your labs are normal but you still don’t feel normal — you deserve a deeper conversation.
READY TO GET STARTED?
Browse professional-grade quercetin and connective tissue support supplements in the Eirene Wellness Apothecary.
Medical Disclaimer
This blog post is intended for educational purposes only and does not constitute medical advice. The information shared reflects integrative and functional medicine perspectives and is not a substitute for personalized evaluation by a qualified healthcare provider. Always consult with your practitioner before beginning any new supplement protocol, particularly if you are taking medications or managing complex medical conditions.
“Healing the Whole You”
EI RENE INTEGRATIVE WELLNESS · WAKE FOREST, NC · EIRENEWELLNESS.COM